Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rockwell Medical (RMTI) Total Debt (2018 - 2026)

Rockwell Medical filings provide 10 years of Total Debt readings, the most recent being $8.8 million for Q4 2025.

  • On a quarterly basis, Total Debt fell 18.6% to $8.8 million in Q4 2025 year-over-year; TTM through Dec 2025 was $8.8 million, a 18.6% decrease, with the full-year FY2025 number at $8.8 million, down 18.6% from a year prior.
  • Total Debt hit $8.8 million in Q4 2025 for Rockwell Medical, down from $10.5 million in the prior quarter.
  • In the past five years, Total Debt ranged from a high of $21.2 million in Q3 2021 to a low of $5.8 million in Q3 2023.
  • Median Total Debt over the past 5 years was $10.8 million (2024), compared with a mean of $12.6 million.
  • Biggest five-year swings in Total Debt: crashed 58.62% in 2023 and later surged 82.76% in 2024.
  • Rockwell Medical's Total Debt stood at $20.6 million in 2021, then plummeted by 55.34% to $9.2 million in 2022, then grew by 17.49% to $10.8 million in 2023, then rose by 0.46% to $10.8 million in 2024, then decreased by 18.6% to $8.8 million in 2025.
  • The last three reported values for Total Debt were $8.8 million (Q4 2025), $10.5 million (Q3 2025), and $11.1 million (Q2 2025) per Business Quant data.